Celldex Therapeutics (NasdaqCM:CLDX) FY Conference November 11, 2025 10:00 AM ET Speaker0All right. Good morning, everyone. Welcome to Guggenheim Healthcare Innovation Conference. Our next presenting company is Celldex Therapeutics. We have a few executives from the company here in our room. We will be chatting here with Tibor Keler, who is the Chief Scientific Officer. We have Diane Young, who is the Chief Medical Officer. We have Sarah Cavanaugh. She's the SVP Corporate Affairs. I have prepared a list of ...